Compounds > voriconazole
Page last updated: 2024-08-25

voriconazole and C gattii Infection

voriconazole has been researched along with C gattii Infection in 49 studies

Research

Studies (49)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's15 (30.61)29.6817
2010's25 (51.02)24.3611
2020's9 (18.37)2.80

Authors

AuthorsStudies
Boekhout, T; Curfs-Breuker, I; Fernández, CM; Illnait-Zaragozi, MT; Martínez, GF; Meis, JF1
Hashimoto, K; Kaeriyama, M; Kimura, A; Mitsuyama, J; Narita, H; Nishikawa, H; Nomura, N; Todo, Y; Yamada, E1
Chen, X; Li, C; Liu, N; Sheng, C; Tu, J; Xu, D; Zhu, T1
Fang, T; Jiang, Y; Li, WP; Lin, Q; Peng, FH; Su, XH; Zheng, XJ1
Akashi, K; Izumikawa, K; Kakeya, H; Kamei, K; Kanda, Y; Kimura, SI; Kishida, M; Kohno, S; Matsuda, M; Miyazaki, T; Miyazaki, Y; Mukae, H; Niki, Y; Ogawa, K; Okada, F; Suzuki, J; Takazono, T; Taniguchi, S; Tateda, K; Yoshida, M1
Kakizaki, MIT; Melhem, MSC1
Hu, J; Li, L; Yang, M; Zhang, X; Zhao, H1
Cheng, J; Tao, R; Xu, L; Zhao, Q; Zhu, B1
da Silva de Bastiani, FWM; de Azevedo Melo, AS; de Castro Spadari, C; Ishida, K; Pisani, PBB1
Li, Y; Liu, H; Pan, H; Wu, H; Zhu, C1
Han, Y; Huang, H; Lan, K; Liang, G; Lin, J; Liu, J; Pan, J; Yang, W; Zeng, L1
Dong, J; Huang, D; Liang, Z; Tang, Y; Wang, K; Wang, Y; Wen, L; Yu, H; Zhang, Y1
Arakawa, S; Fujita, K; Hayashi, S; Muramatsu, H; Nakao, M; Sato, H; Tomita, S1
Bonington, A; Choi, C; Kosmidis, C; Lodhi, A; Singh, B1
da Silva Ruiz, L; Gonçalves Silva, E; Latercia Tranches Dias, A; Marilia de Souza Silva, S; Rodrigues Paula, C1
Almeida-Paes, R; Brito-Santos, F; Cardarelli-Leite, P; da Silva, SA; Fialho, MM; Fortes, ST; Lázera, MDS; Morales, BP; Nascimento, CR; Nishikawa, MM; Santos, LO; Santos, W; Trilles, L1
Al Jalali, V; Eberl, S; Sauermann, R; Zeitlinger, M1
Akaiwa, Y; Miyamoto, T; Norimine, S; Numahata, K; Onoue, H; Yoshizawa, K1
Fujioka, K; Hamasaki, Y; Kagami, S; Kinoshita, Y; Nagai, T; Shishido, S; Urushihara, M1
Hatipoglu, H; Hatipoglu, N1
Chang, CC; Coovadia, Y; Dorasamy, A; French, M; Lewin, S; Mahabeer, Y; Mlisana, K; Moosa, MY; Naidu, D; Ndung'u, T1
Chen, D; Chen, M; Dai, C; Huang, X; Li, Y; Wang, L; Wang, X; Xu, X; Yang, L; Yao, D; Yu, C; Yu, X1
Alencar, LP; Bandeira, TJPG; Brilhante, RSN; Cordeiro, RA; Evangelista, AJJ; Franco, JDS; Marques, FJF; Melo, CVS; Oliveira, JS; Rocha, MFG; Serpa, R; Sidrim, JJC1
Altamirano, R; Córdoba, S; Davel, G; Isla, MG; Szusz, W; Vivot, W1
Busso-Lopes, AF; Kamei, K; Lyra, L; Mikami, Y; Moretti, ML; Peron, IH; Reichert-Lima, F; Schreiber, AZ; Taguchi, H1
Capilla, J; Guarro, J; López-Fernández, L; Mayayo, E; Thomson, P1
Bhat, V; Khattry, N; Toshniwal, M; Vira, H1
Fukuda, Y; Imamura, Y; Izumikawa, K; Kakeya, H; Kohno, S; Mitsuyama, J; Miyazaki, T; Mukae, H; Nakamura, S; Nishikawa, H; Saijo, T; Takazono, T; Tanaka, A; Tashiro, M; Yamamoto, K; Yamamoto, Y; Yanagihara, K1
Buil, JA; Díaz-Cascajosa, J; Roselló, N; Sanchez, F; Vela, JI1
Calvo, E; Guarro, J; Pastor, FJ; Pujol, I; Rodríguez, MM1
Chang, MR; Dias, AL; Gambale, V; Paula, CR; Prates, RA; Ribeiro, MS; Ruiz, Lda S; Silva, EG1
de Assis Baroni, F; Gambale, W; Paula, CR; Silva, EG1
Chang, YC; Dolan, MA; Garraffo, HM; Ghannoum, MA; Kwon-Chung, KJ; Sionov, E1
Allizond, V; Banche, G; Cuffini, AM; Fucale, G; Mandras, N; Roana, J; Scalas, D; Tullio, V1
Adachi, Y; Araki, K; Ikeda, T; Ishikawa, S; Kadowaki, T; Kimura, M; Kobayashi, K; Nagaoka, S; Wakabayashi, K; Yano, S1
Costa, CR; de Fátima Lisboa Fernandes, O; de Paula, JA; de Souza Lino Junior, R; do Rosário Rodrigues Silva, M; Hasimoto E Souza, LK; Vinaud, MC1
Aller, AI; Canton, E; Castañón-Olivares, LR; Chowdhary, A; Cordoba, S; Cuenca-Estrella, M; Espinel-Ingroff, A; Fothergill, A; Fuller, J; Govender, N; Hagen, F; Illnait-Zaragozi, MT; Johnson, E; Kidd, S; Lass-Flörl, C; Lockhart, SR; Martins, MA; Meis, JF; Melhem, MS; Ostrosky-Zeichner, L; Pelaez, T; Pfaller, MA; Schell, WA; St-Germain, G; Trilles, L; Turnidge, J1
Fothergill, AW; Rinaldi, MG; Sutton, DA; Yildiran, ST1
Adou-Bryn, KD; Buisson, Y; Chandenier, J; Douchet, C; Kombila, M; Richard-Lenoble, D; Sar, B; Swinne, D; Thérizol-Ferly, M1
Chang, CS; Chang, HW; Chang, WN; Chien, CC; Huang, CR; Lee, PY; Lei, CB; Lu, CH1
Kofla, G; Ruhnke, M1
Baró-Tomás, T; Jiménez-Cabello, T; Morera-López, Y; Torres-Rodríguez, JM1
Black, TA; Hare, R; Loebenberg, D; Mann, PA; McNicholas, PM; Mendrick, CA; Norris, CC; Patel, R; Sabatelli, F1
Aperis, G; Mylonakis, E1
Casadevall, A; Mavrogiorgos, N; Nosanchuk, JD; Zaragoza, O1
Aperis, G; Mylonakis, E; Spanakis, EK1
Guarro, J; Mariné, M; Pastor, FJ; Rodríguez, MM; Serena, C1
Alvarado-Ramírez, E; Murciano, F; Sellart, M; Torres-Rodríguez, JM1
Discher, T; Friese, G; Füssle, R; Lohmeyer, J; Schmalreck, A1

Reviews

6 review(s) available for voriconazole and C gattii Infection

ArticleYear
CRYPTOCOCCOSIS: A bibliographic narrative review on antifungal resistance.
    Anais da Academia Brasileira de Ciencias, 2023, Volume: 95, Issue:suppl 1

    Topics: Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Fungal; Humans; Microbial Sensitivity Tests; Triazoles; Voriconazole

2023
Combination antifungal therapy for invasive fungal infections in children and adults.
    Expert review of anti-infective therapy, 2013, Volume: 11, Issue:5

    Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Caspofungin; Child; Cryptococcosis; Cryptococcus; Drug Therapy, Combination; Echinocandins; Humans; Lipopeptides; Pyrimidines; Triazoles; Voriconazole

2013
Pleural effusion as the initial clinical presentation in disseminated cryptococcosis and fungaemia: an unusual manifestation and a literature review.
    BMC infectious diseases, 2015, Sep-22, Volume: 15

    Topics: Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Fluconazole; Flucytosine; Fungemia; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Pleural Effusion; Voriconazole

2015
Voriconazole: review of a broad spectrum triazole antifungal agent.
    Expert opinion on pharmacotherapy, 2005, Volume: 6, Issue:7

    Topics: Administration, Oral; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Cryptococcosis; Cyclic N-Oxides; Disease Models, Animal; Drug Resistance, Fungal; Drug Therapy, Combination; Echinocandins; Fluconazole; Humans; Injections, Intravenous; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Peptides, Cyclic; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole

2005
Newer triazole antifungal agents: pharmacology, spectrum, clinical efficacy and limitations.
    Expert opinion on investigational drugs, 2006, Volume: 15, Issue:6

    Topics: Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Drug Administration Schedule; Drug Evaluation, Preclinical; Drug Resistance, Fungal; Drug Therapy, Combination; Humans; Pyrimidines; Randomized Controlled Trials as Topic; Thiazoles; Triazoles; Voriconazole

2006
New agents for the treatment of fungal infections: clinical efficacy and gaps in coverage.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2006, Oct-15, Volume: 43, Issue:8

    Topics: Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Clinical Trials as Topic; Cryptococcosis; Echinocandins; Fever; Humans; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Neutropenia; Peptides, Cyclic; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2006

Trials

1 trial(s) available for voriconazole and C gattii Infection

ArticleYear
Efficacy and safety of isavuconazole against deep-seated mycoses: A phase 3, randomized, open-label study in Japan.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2023, Volume: 29, Issue:2

    Topics: Antifungal Agents; Aspergillosis; Cryptococcosis; Humans; Invasive Fungal Infections; Japan; Mucormycosis; Pulmonary Aspergillosis; Triazoles; Voriconazole

2023

Other Studies

42 other study(ies) available for voriconazole and C gattii Infection

ArticleYear
In Vitro activity of the new azole isavuconazole (BAL4815) compared with six other antifungal agents against 162 Cryptococcus neoformans isolates from Cuba.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:4

    Topics: Antifungal Agents; Azoles; Cryptococcosis; Cryptococcus neoformans; Cuba; Humans; Microbial Sensitivity Tests; Nitriles; Pyridines; Triazoles

2008
In vitro and in vivo antifungal activities of T-2307, a novel arylamidine.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:4

    Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Benzamidines; Candida albicans; Candidiasis; Cryptococcosis; Cryptococcus neoformans; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Mycoses; Specific Pathogen-Free Organisms; Treatment Outcome

2008
Lanosterol 14α-demethylase (CYP51)/histone deacetylase (HDAC) dual inhibitors for treatment of Candida tropicalis and Cryptococcus neoformans infections.
    European journal of medicinal chemistry, 2021, Oct-05, Volume: 221

    Topics: 14-alpha Demethylase Inhibitors; Antifungal Agents; Candida tropicalis; Candidiasis, Cutaneous; Cryptococcosis; Cryptococcus neoformans; Cytochrome P450 Family 51; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Histone Deacetylase Inhibitors; Histone Deacetylases; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship

2021
Case report: a special case of cryptococcal infection-related inflammatory syndrome in a non-HIV infected and non-transplant patient.
    BMC neurology, 2022, Jul-06, Volume: 22, Issue:1

    Topics: Adult; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Humans; Male; Meningitis, Cryptococcal; Meningoencephalitis; Syndrome; Voriconazole

2022
Cryptococcosis in Patients following Kidney Transplantation: A 9-Year Retrospective Clinical Analysis at a Chinese Tertiary Hospital.
    BioMed research international, 2019, Volume: 2019

    Topics: Adult; Amphotericin B; Antifungal Agents; China; Cryptococcosis; Cryptococcus; Female; Fluconazole; Humans; Kidney Transplantation; Male; Middle Aged; Retrospective Studies; Tertiary Care Centers; Voriconazole

2019
An AIDS patient with urine retention.
    BMC infectious diseases, 2019, Dec-12, Volume: 19, Issue:1

    Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; China; Cryptococcosis; Cryptococcus neoformans; Delayed Diagnosis; Diagnostic Errors; Fluconazole; Flucytosine; Humans; Male; Middle Aged; Pneumonia, Pneumocystis; Prostatitis; Treatment Outcome; Urinary Retention; Voriconazole

2019
Efficacy of voriconazole in vitro and in invertebrate model of cryptococcosis.
    Archives of microbiology, 2020, Volume: 202, Issue:4

    Topics: Amphotericin B; Animals; Antifungal Agents; Biofilms; Cryptococcosis; Cryptococcus gattii; Disease Models, Animal; Fluconazole; Humans; Larva; Microbial Sensitivity Tests; Moths; Voriconazole

2020
Kolliphor® HS 15-cyclodextrin Complex for the Delivery of Voriconazole: Preparation, Characterization, and Antifungal Activity.
    Current drug metabolism, 2020, Volume: 21, Issue:5

    Topics: Animals; Antifungal Agents; Aspergillus niger; beta-Cyclodextrins; Candida albicans; Cryptococcosis; Cryptococcus neoformans; Drug Carriers; Drug Liberation; Female; Male; Mice; Microbial Sensitivity Tests; Polyethylene Glycols; Stearates; Surface-Active Agents; Voriconazole

2020
First case report of Cryptococcus laurentii knee infection in a previously healthy patient.
    BMC infectious diseases, 2020, Sep-17, Volume: 20, Issue:1

    Topics: Administration, Oral; Adult; Amphotericin B; Antifungal Agents; Arthritis, Infectious; Cryptococcosis; Cryptococcus; Debridement; Diagnostic Errors; Fluconazole; Focal Infection; Humans; Knee; Male; Skin Diseases, Bacterial; Voriconazole

2020
Crazy-paving patterns as rare radiological manifestations of pulmonary cryptococcosis: a case report.
    BMC pulmonary medicine, 2021, Mar-12, Volume: 21, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Bronchoscopy; Cryptococcosis; Flucytosine; Humans; Lung Diseases, Fungal; Male; Middle Aged; Tomography, X-Ray Computed; Voriconazole

2021
Treatment of Cryptococcus gattii Infection Using Voriconazole.
    Internal medicine (Tokyo, Japan), 2021, Nov-15, Volume: 60, Issue:22

    Topics: Adult; Antifungal Agents; Cryptococcosis; Cryptococcus gattii; Cryptococcus neoformans; Fluconazole; Humans; Male; Microbial Sensitivity Tests; Voriconazole

2021
Use of voriconazole in non-meningeal cryptococcosis.
    Infectious diseases (London, England), 2017, Volume: 49, Issue:9

    Topics: Cryptococcosis; Cryptococcus neoformans; Humans; Voriconazole

2017
Modulatory effect of voriconazole on the production of proinflammatory cytokines in experimental cryptococcosis in mice with severe combined immunodeficiency.
    Journal de mycologie medicale, 2018, Volume: 28, Issue:1

    Topics: Amphotericin B; Animals; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Cytokines; Disease Models, Animal; Drug Therapy, Combination; Inflammation; Lung; Lung Diseases, Fungal; Mice; Severe Combined Immunodeficiency; Voriconazole

2018
Comparative antifungal susceptibility analyses of Cryptococcus neoformans VNI and Cryptococcus gattii VGII from the Brazilian Amazon Region by the Etest, Vitek 2, and the Clinical and Laboratory Standards Institute broth microdilution methods.
    Medical mycology, 2019, Oct-01, Volume: 57, Issue:7

    Topics: Amphotericin B; Antifungal Agents; Brazil; Clinical Laboratory Techniques; Cryptococcosis; Cryptococcus gattii; Cryptococcus neoformans; Disk Diffusion Antimicrobial Tests; Drug Resistance, Fungal; Flucytosine; Humans; Microbial Sensitivity Tests; Voriconazole

2019
In vitro activity of voriconazole and amphotericin B against Candida albicans, Candida krusei, and Cryptococcus neoformans in human cerebrospinal fluid.
    Infection, 2019, Volume: 47, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candidiasis; Central Nervous System Infections; Cerebrospinal Fluid; Cryptococcosis; Cryptococcus neoformans; Humans; Voriconazole

2019
[Cryptococcal meningoencephalitis in an immunocompetent patient caused by late onset exacerbation].
    Rinsho shinkeigaku = Clinical neurology, 2019, Apr-25, Volume: 59, Issue:4

    Topics: Adult; Amphotericin B; Antifungal Agents; Antigens, Fungal; Biomarkers; Cryptococcosis; Cryptococcus neoformans; Disease Progression; Humans; Immunocompetence; Immunoglobulin G; Magnetic Resonance Imaging; Male; Meningoencephalitis; Methylprednisolone; Neuroimaging; Pulse Therapy, Drug; Treatment Outcome; Voriconazole

2019
Successful treatment with voriconazole combined with amphotericin B-liposome for fluconazole-resistant pulmonary cryptococcosis after renal transplantation.
    CEN case reports, 2019, Volume: 8, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Antigens, Fungal; Combined Modality Therapy; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Fungal; Female; Fluconazole; Humans; Kidney Transplantation; Lung Diseases, Fungal; Radiography, Thoracic; Treatment Outcome; Voriconazole; Young Adult

2019
Comparison of Etests and Vitek 2 ® to broth microdilution for the susceptibility testing of Cryptococcus neoformans.
    Diagnostic microbiology and infectious disease, 2014, Volume: 80, Issue:4

    Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Disk Diffusion Antimicrobial Tests; Fluconazole; Flucytosine; Humans; South Africa; Voriconazole

2014
Inhibition of heat-shock protein 90 enhances the susceptibility to antifungals and reduces the virulence of Cryptococcus neoformans/Cryptococcus gattii species complex.
    Microbiology (Reading, England), 2016, Volume: 162, Issue:2

    Topics: Amphotericin B; Animals; Antifungal Agents; Biofilms; Caenorhabditis elegans; Cell Membrane; Cryptococcosis; Cryptococcus gattii; Cryptococcus neoformans; Ergosterol; Fluconazole; HSP90 Heat-Shock Proteins; Humans; Itraconazole; Melanins; Microbial Sensitivity Tests; Plankton; Voriconazole

2016
Susceptibility profile and epidemiological cut-off values of Cryptococcus neoformans species complex from Argentina.
    Mycoses, 2016, Volume: 59, Issue:6

    Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Argentina; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Fungal; Epidemiologic Methods; Fluconazole; Flucytosine; HIV Infections; Humans; Itraconazole; Meningitis, Cryptococcal; Microbial Sensitivity Tests; Triazoles; Voriconazole

2016
Evaluation of antifungal combination against Cryptococcus spp.
    Mycoses, 2016, Volume: 59, Issue:9

    Topics: Amphotericin B; Antifungal Agents; Brazil; Cryptococcosis; Cryptococcus; Cryptococcus neoformans; Drug Combinations; Drug Synergism; Fluconazole; Flucytosine; Genotype; Humans; Itraconazole; Microbial Sensitivity Tests; Molecular Typing; Naphthalenes; Polymorphism, Restriction Fragment Length; Terbinafine; Voriconazole

2016
Combined antifungal therapy against systemic murine infections by rare Cryptococcus species.
    Mycoses, 2017, Volume: 60, Issue:2

    Topics: Administration, Intravenous; Administration, Oral; Amphotericin B; Animals; Antifungal Agents; Cryptococcosis; Cryptococcus; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Fluconazole; Immunocompromised Host; Lung; Mice; Microbial Sensitivity Tests; Spleen; Voriconazole

2017
Cryptococcus laurentii diarrhea post hematopoietic stem cell transplant.
    Transplant infectious disease : an official journal of the Transplantation Society, 2017, Volume: 19, Issue:2

    Topics: Administration, Intravenous; Administration, Oral; Adult; Antibiotic Prophylaxis; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; C-Reactive Protein; Carmustine; Cryptococcosis; Cryptococcus; Cytarabine; Diarrhea; Etoposide; Feces; Fluconazole; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Melphalan; Microbial Sensitivity Tests; Transplantation Conditioning; Transplantation, Autologous; Voriconazole

2017
In vitro and in vivo antifungal activities of T-2307, a novel arylamidine, against Cryptococcus gattii: an emerging fungal pathogen.
    The Journal of antimicrobial chemotherapy, 2017, 06-01, Volume: 72, Issue:6

    Topics: Amidines; Amphotericin B; Animals; Antifungal Agents; Brain; Cryptococcosis; Cryptococcus gattii; Cryptococcus neoformans; Disease Models, Animal; Drug Discovery; Drug Resistance, Fungal; Fluconazole; Humans; Lung; Lung Diseases, Fungal; Mice; Microbial Sensitivity Tests; Voriconazole

2017
Management of endogenous cryptococcal endophthalmitis with voriconazole.
    Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 2009, Volume: 44, Issue:6

    Topics: Aged, 80 and over; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Endophthalmitis; Eye Infections, Fungal; Female; Humans; Pyrimidines; Triazoles; Voriconazole

2009
Antifungal therapy in a murine model of disseminated infection by Cryptococcus gattii.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:10

    Topics: Amphotericin B; Animals; Antifungal Agents; Cryptococcosis; Cryptococcus gattii; Male; Mice; Pyrimidines; Triazoles; Voriconazole

2010
Combination efficacy of voriconazole and amphotericin B in the experimental disease in immunodeficient mice caused by fluconazole-resistant Cryptococcus neoformans.
    Mycopathologia, 2011, Volume: 171, Issue:4

    Topics: Amphotericin B; Animals; Antifungal Agents; Brain; Colony Count, Microbial; Cryptococcosis; Cryptococcus neoformans; Disease Models, Animal; Drug Resistance, Fungal; Drug Therapy, Combination; Fluconazole; Lung; Mice; Mice, Inbred BALB C; Mice, SCID; Pyrimidines; Rodent Diseases; Survival Analysis; Treatment Outcome; Triazoles; Voriconazole; Yeasts

2011
Voriconazole, combined with amphotericin B, in the treatment for pulmonary cryptococcosis caused by C. neoformans (serotype A) in mice with severe combined immunodeficiency (SCID).
    Mycopathologia, 2012, Volume: 173, Issue:5-6

    Topics: Amphotericin B; Animals; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Disease Models, Animal; Drug Therapy, Combination; Lung; Lung Diseases, Fungal; Mice; Mice, SCID; Pyrimidines; Severe Combined Immunodeficiency; Survival Analysis; Treatment Outcome; Triazoles; Voriconazole

2012
Identification of a Cryptococcus neoformans cytochrome P450 lanosterol 14α-demethylase (Erg11) residue critical for differential susceptibility between fluconazole/voriconazole and itraconazole/posaconazole.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:3

    Topics: 14-alpha Demethylase Inhibitors; Animals; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Fungal; Female; Fluconazole; Fungal Proteins; Genotype; Humans; Itraconazole; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mutation, Missense; Phenylalanine; Pyrimidines; Sterol 14-Demethylase; Survival Rate; Triazoles; Tyrosine; Voriconazole

2012
A case of fluconazole, voriconazole-resistant Cryptococcus neoformans isolated from and immunocompetent patient.
    Journal of chemotherapy (Florence, Italy), 2011, Volume: 23, Issue:6

    Topics: Adult; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Multiple, Fungal; Fluconazole; Humans; Immunocompetence; Male; Pyrimidines; Triazoles; Voriconazole; Young Adult

2011
Sarcoid-like reaction in Cryptococcus neoformans infection.
    BMJ case reports, 2012, Jul-27, Volume: 2012

    Topics: Administration, Oral; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Diagnosis, Differential; Female; Humans; Itraconazole; Middle Aged; Pyrimidines; Radiography, Thoracic; Sarcoidosis; Triazoles; Voriconazole

2012
Effects of Pimenta pseudocaryophyllus (Gomes) L. R. Landrum, on melanized and non-melanized Cryptococcus neoformans.
    Mycopathologia, 2012, Volume: 174, Issue:5-6

    Topics: Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Fungal; Fungal Capsules; Humans; Melanins; Microbial Sensitivity Tests; Pimenta; Plant Extracts; Pyrimidines; Triazoles; Voriconazole

2012
Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for fluconazole, itraconazole, posaconazole, and voriconazole.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:11

    Topics: Antifungal Agents; Australia; Cryptococcosis; Cryptococcus gattii; Drug Resistance, Fungal; Europe; Fluconazole; Humans; India; Itraconazole; Microbial Sensitivity Tests; North America; Pyrimidines; South Africa; South America; Triazoles; Voriconazole

2012
In vitro susceptibilities of cerebrospinal fluid isolates of Cryptococcus neoformans collected during a ten-year period against fluconazole, voriconazole and posaconazole (SCH56592).
    Mycoses, 2002, Volume: 45, Issue:9-10

    Topics: Antifungal Agents; Cerebrospinal Fluid; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Microbial; Fluconazole; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2002
In vitro activity of amphotericin B, fluconazole and voriconazole against 162 Cryptococcus neoformans isolates from Africa and Cambodia.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2004, Volume: 23, Issue:6

    Topics: Africa; Amphotericin B; Antifungal Agents; Cambodia; Cryptococcosis; Cryptococcus neoformans; Developing Countries; Drug Resistance, Fungal; Female; Fluconazole; Humans; Male; Microbial Sensitivity Tests; Pyrimidines; Risk Assessment; Sampling Studies; Triazoles; Voriconazole

2004
Serotypes of clinical cerebrospinal fluid Cryptococcus neoformans isolates from southern Taiwan and their in vitro susceptibilities to amphotericin B, fluconazole, and voriconazole.
    Japanese journal of infectious diseases, 2004, Volume: 57, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Cerebrospinal Fluid; Colony Count, Microbial; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Fungal; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Serotyping; Taiwan; Triazoles; Voriconazole

2004
Cryptococcus gattii: in vitro susceptibility to the new antifungal albaconazole versus fluconazole and voriconazole.
    Medical mycology, 2005, Volume: 43, Issue:6

    Topics: Animals; Antifungal Agents; Cryptococcosis; Cryptococcus; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Quinazolines; Soil Microbiology; Triazoles; Voriconazole

2005
In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts.
    Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Cryptococcosis; Cryptococcus; Drug Resistance, Fungal; Fluconazole; Fungi; Humans; In Vitro Techniques; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole

2006
Efficacy of voriconazole in experimental Cryptococcus neoformans infection.
    Mycopathologia, 2006, Volume: 162, Issue:2

    Topics: Animals; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Female; Lung Diseases, Fungal; Mice; Mice, Inbred C57BL; Polysaccharides; Pyrimidines; Triazoles; Voriconazole

2006
Efficacy of voriconazole in a murine model of cryptococcal central nervous system infection.
    The Journal of antimicrobial chemotherapy, 2007, Volume: 60, Issue:1

    Topics: Animals; Antifungal Agents; Brain; Central Nervous System Fungal Infections; Cryptococcosis; Cryptococcus neoformans; Disease Models, Animal; Humans; Lung; Male; Mice; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2007
MICs and minimum fungicidal concentrations of posaconazole, voriconazole and fluconazole for Cryptococcus neoformans and Cryptococcus gattii.
    The Journal of antimicrobial chemotherapy, 2008, Volume: 62, Issue:1

    Topics: Animals; Antifungal Agents; Bird Diseases; Columbidae; Cryptococcosis; Cryptococcus; Fluconazole; Humans; Microbial Sensitivity Tests; Microbial Viability; Pyrimidines; Triazoles; Voriconazole

2008
Development of azole resistance during fluconazole maintenance therapy for AIDS-associated cryptococcal disease.
    AIDS (London, England), 2001, Nov-23, Volume: 15, Issue:17

    Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Chorioretinitis; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Multiple, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Meningitis, Cryptococcal; Pneumonia; Prednisolone; Pyrimidines; Triazoles; Voriconazole

2001